Home/Filings/4/0001179110-21-011222
4//SEC Filing

Toselli Richard M. 4

Accession 0001179110-21-011222

CIK 0001292519other

Filed

Dec 22, 7:00 PM ET

Accepted

Dec 23, 4:02 PM ET

Size

5.2 KB

Accession

0001179110-21-011222

Insider Transaction Report

Form 4
Period: 2021-12-21
Toselli Richard M.
Chief Medical Officer
Transactions
  • Tax Payment

    Common Stock

    2021-12-21$0.54/sh16$96,201 total
Footnotes (1)
  • [F1]Represents shares sold by the reporting person pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2018 to satisfy tax withholding obligations applicable to the vesting of 50 stock-settled restricted stock units ("RSUs"). The vesting schedule for the RSUs was amended on June 11, 2019, and the remaining shares underlying the unvested RSUs vested in equal semi-annual installments on June 18 and December 18 until fully vested on December 18, 2021.

Issuer

INVIVO THERAPEUTICS HOLDINGS CORP.

CIK 0001292519

Entity typeother

Related Parties

1
  • filerCIK 0001710549

Filing Metadata

Form type
4
Filed
Dec 22, 7:00 PM ET
Accepted
Dec 23, 4:02 PM ET
Size
5.2 KB